Lab Information

Ana Copaescu (MD/PhD)

Investigator
Clinical Research Unit
Department of Medicine (McGill)

Research Profile

 Fundamental: 20%
 Clinical: 60%
 Epidemiology: 20%
 Evaluation: 0%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Immune-mediated adverse drug reactions • severe cutaneous adverse reaction • point-of-care solutions • risk stratification tools • in vivo diagnostic tools • ex vivo diagnostic tools • clinical trials

Research Interests

My research focuses on drug allergy−related pathologies, including their clinical identification, diagnostic methods and management. The ongoing clinical and translational research projects aim to improve precision diagnosis, including mechanisms to remove drug allergy labels and develop diagnostic tools. Additionally, I aim to advance our understanding of the complex, severe, delayed drug reactions associated with significant acute and long-term morbidity and mortality. These developments allow me to be part of a network of international collaborators, an excellent platform for exchanging and developing new projects. Addressing the significant health issue of immune-mediated drug allergy will lead to high-level research output that will translate into improvement in healthcare, locally and internationally.


Team Members

Name Position

Latest Publications

  1. Copaescu, A. M., Vogrin, S., Douglas, A., Turner, N. A., Phillips, E. J., Holmes, N. E. & Trubiano, J. A. (2024). Risk of Self-Reported Penicillin Allergy Despite Removal of Penicillin Allergy Label: Secondary Analysis of the PALACE Randomized Clinical Trial. JAMA network open, vol. 7, p. e2429621.
  2. Barbaud, A., Goncalo, M., Mockenhaupt, M., Copaescu, A. & Phillips, E. J. (2024). Delayed skin testing for systemic medications: helpful or not?. The journal of allergy and clinical immunology. In practice.
  3. Copaescu, A. M. & Trubiano, J. A. (2024). Optimizing How We Measure Quality of Life in Drug Hypersensitivity. The journal of allergy and clinical immunology. In practice, vol. 12, p. 1592-1593.
  4. Stehlin, F., Khoudja, R. Y., Lee, D., Toupin, J.-F., Isabwe, G. A. C., Fein, M., Al-Otaibi, I., Phillips, E. J., Trubiano, J. A. & Copaescu, A.-M. (2024). Skin testing and challenge in patients with immediate hypersensitivity reactions to gadolinium-based contrast agents identify safe future options. Allergology international : official journal of the Japanese Society of Allergology.
  5. Copaescu, A. M., Li, L., Blumenthal, K. G. & Trubiano, J. A. (2024). How to Define and Manage Low-Risk Drug Allergy Labels. The journal of allergy and clinical immunology. In practice, vol. 12, p. 1095-1106.
  6. Sillcox, C., Gabrielli, S., O'Keefe, A., McCusker, C., Abrams, E. M., Eiwegger, T., Atkinson, A., Kim, V., Copaescu, A.-M., Ben-Shoshan, M., Sillcox, C., Gabrielli, S., O'Keefe, A., McCusker, C., Abrams, E. M., Eiwegger, T., Atkinson, A., Kim, V., Copaescu, A.-M. & Ben-Shoshan, M. (2024). Assessing Pediatric Cephalosporin Allergic Reactions Through Direct Graded Oral Challenges. The journal of allergy and clinical immunology. In practice, vol. 12, p. 156-164.e4.
  7. Lee, E. Y., Copaescu, A. M., Trubiano, J. A., Phillips, E. J., Wolfson, A. R. & Ramsey, A. (2023). Drug Allergy in Women. The journal of allergy and clinical immunology. In practice, vol. 11, p. 3615-3623.
  8. Stehlin, F., Khoudja, R. Y., Al-Otaibi, I., ALMuhizi, F., Fein, M., Gilbert, L., Tsoukas, C., Ben-Shoshan, M., Copaescu, A.-M. & Clarisse Isabwe, G. A. (2024). COVID-19 booster vaccine acceptance following allergy evaluation in individuals with allergies. The journal of allergy and clinical immunology. In practice, vol. 12, p. 242-245.e2.
  9. Copaescu, A. M., Vogrin, S., James, F., Chua, K. Y. L., Rose, M. T., De Luca, J., Waldron, J., Awad, A., Godsell, J., Mitri, E., Lambros, B., Douglas, A., Youcef Khoudja, R., Isabwe, G. A. C., Genest, G., Fein, M., Radojicic, C., Collier, A., Lugar, P., Stone, C., Ben-Shoshan, M., Turner, N. A., Holmes, N. E., Phillips, E. J. & Trubiano, J. A. (2023). Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial. JAMA internal medicine, vol. 183, p. 944-952.
  10. AlOtaibi, I., Almuhizi, F., Ton-Leclerc, S., Fein, M., Tsoukas, C., Garvey, L. H., Lee, D., Ben-Shoshan, M., Isabwe, G. A. C. & Copaescu, A. M. (2023). Anaphylaxis induced by mRNA COVID-19 vaccines: follow-up and booster dose after previous desensitization. Frontiers in allergy, vol. 4, p. 1056619.
More on PubMed 



See also

Card image
Moshe
Ben-Shoshan


See profile
Card image
Christos
Tsoukas


See profile
Card image
Geneviève
Genest


See profile